Ligand Pharmaceuticals, Inc. (LGND)
231.32
+2.84
(+1.24%)
USD |
NASDAQ |
Apr 24, 16:00
231.27
-0.05
(-0.02%)
After-Hours: 20:00
Ligand Pharmaceuticals Market Cap : 4.613B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.550B |
| Johnson & Johnson | 547.64B |
| ADMA Biologics, Inc. | 2.682B |
| Intuitive Surgical, Inc. | 170.78B |
| Establishment Labs Holdings, Inc. | 1.943B |
Market Cap Related Metrics
| PE Ratio | 39.65 |
| PS Ratio | 17.45 |
| Price to Book Value | 4.535 |
| Price to Free Cash Flow | 122.95 |
| Price | 231.32 |
| Earnings Yield | 2.52% |
| Operating PE Ratio | 99.10 |
| Normalized PE Ratio | 74.98 |